Tamarly Lists
A numbered list each weekday, from public records
Each list is built from SEC filings, ClinicalTrials.gov, FDA records and OECD data, with the source and date of every line. Research, not investment advice.
- Monday: 10 operating companies that raised $5 million to $100 million this week41 operating companies reported raising $5 million to $100 million in SEC Form D filings from 27 October 2026 to 2 November 2026, $799.6 million in total, against 39 and $1.0 billion the week before. As of 3 November 2026.
- Tuesday: 12 medicines that moved to the next trial phase this week30 medicines from company sponsors entered a higher trial phase in trials registered on ClinicalTrials.gov from 27 October 2026 to 2 November 2026; the 12 below lead by phase and trial size. As of 3 November 2026.
- Wednesday: 10 countries where government borrowing got more expensive6 of 6 countries saw their 10-year government bond yield rise in the latest month of OECD data; the 6 below had the largest increase. As of 3 November 2026.
- Thursday: 7 trends in life sciences investment this weekFrom 27 October 2026 to 2 November 2026, 15 biotech and health care companies reported $24.1 million of new private money in SEC Form D filings (company count down 36% on the 4-week average of 23.5), and companies registered 571 new trials, 233 of them at Phase 3. As of 3 November 2026.
- Friday: 20 sectors where AI shows up most in company filingsAcross 900 companies filing with the SEC, in 39 sectors, these 20 mention AI most often in results releases, management discussion and risk factors filed with the SEC from 5 August 2026 to 2 November 2026. As of 3 November 2026.